Vanda Pharmaceuticals Inc (VNDA) stock news · rev $216.1M
Vanda Pharmaceuticals Inc (VNDA) is a biotechnology company listed on NASDAQ.
This VNDA news page leads with what Vanda Pharmaceuticals Inc filed — not a scraped headline mill.
No cached 8-K sentence for VNDA yet. We will not pad this page with generic market recap.
Latest reported VNDA revenue for 2025-12-31 was $216.1M. Net income was -$220.5M. Revenue was up 8.7% from 2024-12-31 to 2025-12-31. VNDA currently screens at market cap $358.4M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the VNDA stock page; for the tape open the quote page.
VNDA stock news FAQ
What are VNDA's latest revenue and net income?
Latest cached Vanda Pharmaceuticals Inc (VNDA) revenue for Dec 31, 2025 was $216.1M. Net income was -$220.5M. Statements: https://lician.com/financials/vnda
How did VNDA revenue change from the prior cached period?
Cached Vanda Pharmaceuticals Inc (VNDA) revenue was up 8.7% from $198.8M (Dec 31, 2024) to $216.1M (Dec 31, 2025). Statements: https://lician.com/financials/vnda
What is VNDA's market cap?
Vanda Pharmaceuticals Inc (VNDA) market cap is $358.4M on the latest cached fundamentals snapshot.
What kind of company is VNDA?
Vanda Pharmaceuticals Inc (VNDA) is a biotechnology company listed on NASDAQ.
Where is VNDA stock news listed?
Cached stock news for Vanda Pharmaceuticals Inc (VNDA) is listed at https://lician.com/news/vnda. Filings: https://lician.com/sec/vnda
Not investment advice.